Priming enhances endotoxin-induced thermal hyperalgesia and mechanical allodynia in rats

Brain Research

Volumn 808, Issue 1, 1998, Pages 13-22

  Cahill, Catherine M ^a,b   Dray, Andy ^b   Coderre, Terence J ^a,c,d  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b Astra Research Centre Montreal   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Allodynia; Central nervous system; Cerebral inflammation; Hyperalgesia; Lipopolysaccharide; Nociception

Indexed keywords

ENDOTOXIN; LIPOPOLYSACCHARIDE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; HEAT SENSITIVITY; HYPERALGESIA; LATERAL BRAIN VENTRICLE; MACROPHAGE ACTIVATION; MALE; MECHANICAL STRESS; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; CEREBRAL VENTRICLES; ENDOTOXINS; HEAT; HYPERALGESIA; INFLAMMATION; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; MALE; PAIN; PAIN THRESHOLD; PHYSICAL STIMULATION; RATS;

EID: 0032511818     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00786-0     Document Type: Article

References (43)

1. Aderm A.A., Cohen D.S., Wright S.D., Cohn Z.A. Bacterial lipopolysaccharides prime macrophages for enhanced release of arachidonic acid metabolites. J. Exp. Med. 164:1986;165-179.
2. Andersson P.-B., Perry V.H., Gordon S. The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience. 48:1992;169-186.
3. Bauer M.K.A., Lieb K., Schulze-Osthoff K., Berger M., Gebicke-Haerter P.J., Bauer J., Fiebick B.L. Expression and regulation of cyclooxygenase-2 in rat microglia. Eur. J. Biochem. 243:1997;726-731.
4. J. Boivie, Central pain, in: P.D. Wall, R. Melzack (Eds.), Textbook of Pain, 3rd edn., Churchill, Livingstone, New York, 1994, pp. 871-902.
5. Boje K.M.K. Cerebrovascular permeability changes during experimental meningitis in the rat. J. Pharmacol. Exp. Ther. 274:1995;1199-1203.
6. J.J. Bonica, Introduction: semantic, epidemiologic and educational issues, in: K.L. Casey (Ed.), Pain and the Central Nervous System Disease: The Central Pain Syndromes, Raven Press, New York, 1991, pp. 13-29.
7. Brightman M.W., Ishihara S., Chang L. Penetration of solutes, viruses, and cells across the blood-brain barrier. Curr. Top. Microbiol. Immunol. 202:1995;63-78.
8. Chao C.C., Hu S., Close K., Sheng W.S., Peterson P.K. Tumor necrosis factor-alpha production by human fetal microglial cells: regulation by other cytokines. Dev. Neurosci. 17:1995;97-105.
9. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of allodynia in the rat paw. J. Neurosci. Methods. 53:1994;55-63.
10. Damoiseaux J., Dopp E., Veraasdonk M., Kamperdijk E., Dijkstra C. Three monoclonal antibodies to antigen presenting cells in the rat with differential influence on cellular interactions. Adv. Exp. Med. Biol. 329:1994;179-184.
11. DeVries H.E., Kuiper J., De Boer A.G., Van Berkel J.C., Breimer D.D. The blood-brain barrier in neuroinflammatory diseases. Pharmacol. Rev. 49:1997;143-155.
12. Dray A. Inflammatory mediators of pain. Br. J. Anaesth. 75:1995;125-131.
13. Elmquist J.K., Breder C.D., Sherin J.E., Scammell T.E., Hickey W.F., Dewitt D., Saper C.B. Intravenous lipopolysaccharide induces cyclooxygenase 2-like immunoreactivity in rat brain perivascular microglia and meningeal macrophages. J. Comp. Neurol. 381:1997;119-128.
14. Hirohashi N., Morrison D.C. Low-dose lipopolysaccharide (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro. Infect. Immun. 64:1996;1011-1015.
15. Kent S., Bluthe R.-M., Kelley K.W., Dantzer R. Sickness behavior as a new target for drug development. Trends Pharmacol. Sci. 13:1992;24-28.
16. J.D. Levine, Arthritis and myositis, in: IASP Refresher Courses, 1996, pp. 351-360.
17. Maier S.F., Wiertelak E.P., Martin D., Watkins L.R. Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin. Brain Res. 623:1993;321-325.
18. Mallat M., Houlgatte R., Brachet P., Prochiantz A. Lipopolysaccharide-stimulated rat brain macrophages release NGF in vitro. Dev. Biol. 133:1989;309-311.
19. Mason P. Lipopolysaccharide induced fever and decreases tail flick latency in awake rats. Neurosci. Lett. 154:1993;134-136.
20. Meller S.T., Dykstra C., Grzybycki D., Murphy S., Gebhart G.F. The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat. Neuropharmacology. 33:1994;1471-1478.
21. Montero-Menei C.N., Sindji L., Garcion E., Mege M., Couez D., Gamelin E., Darcy F. Early events of the inflammatory reaction induced in rat brain by lipopolysaccharide intracerebral injection: relative contribution of peripheral monocytes and activated microglia. Brain Res. 724:1996;55-66.
22. Oka T., Oka K., Hosoi M., Hori T. Intracerebroventricular injection of interleukin-6 induces thermal hyperalgesia in rats. Brain Res. 692:1995;123-128.
23. Perry V.H., Andersson P.-B. The inflammatory response in the CNS. Neuropathol. Appl. Neurobiol. 18:1992;454-459.
24. Perry V.H., Andersson P.-B., Gordon S. Macrophages and inflammation in the central nervous system. Trends Neurosci. 16:1993;268-273.
25. Petito C.K., Cash K.S. Blood brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann. Neurol. 32:1992;658-666.
26. Power C., Kong P.A., Crawford T.O., Wesselingh S., Glass J.D., McArthur J.C. Cerebral white matter changes in acquired immunodeficiency syndrome dementia alterations of the blood-brain barrier. Ann. Neurol. 34:1993;339-350.
27. Quagliarello V.J., Ma A., Stukenbrok H., Palade G.E. Ultrastructural localization of albumin transport across the cerebral microvasculature during experimental meningitis in the rat. J. Exp. Med. 174:1991;657-672.
28. Rothwell N.J., Hopkins S.J. Cytokines and the nervous system: II. Actions of mechanisms of action. Trends Neurosci. 18:1995;130-136.
29. Szczenpanik A.M., Fishkin R.J., Rush D.K., Wilmont C.A. Effects of chronic intrahippocampal infusion of lipopolysaccharide in the rat. Neuroscience. 70:1996;57-65.
30. R.R. Tasker, G. De Carvalbo, J.O. Dostrovsky, The history of central pain syndromes, with observations concerning pathophysiology and treatment, in: K.L. Casey (Ed.), Pain and the Central Nervous System Disease: The Central Pain Syndromes, Raven Press, New York, 1991, pp. 13-29.
31. E. Tuomunen, Breaching the blood-brain barrier, Sci. Am. Feb. (1993) 80-84.
32. Van Dam A.-M., Bauer J., Tilders F.J.H., Berkenbosch F. Endotoxin-induced appearance of immunoreactive interleukin-1β in ramified microglia in rat brain: a light and electron microscope study. Neuroscience. 65:1995;815-826.
33. 2 receptor antagonist treatment. Pain. 65:1996;211-219.
34. Watkins L.R., Goehler L.E., Relton J., Brewer M.T., Maier S.F. Mechanisms of tumor necrosis factor-α (TNF-α) hyperalgesia. Brain Res. 692:1995;244-250.
35. Watkins L.R., Wiertelak E.P., Furness L.E., Maier S.F. Illness-induced hyperalgesia is mediated by spinal neuropeptides and excitatory amino acids. Brain Res. 664:1994;17-24.
36. Watkins L.R., Wiertelak E.P., Goehler L.E., Smith K.P., Martin D., Maier S.F. Characterization of cytokine-induced hyperalgesia. Brain Res. 654:1994;15-26.
37. Watkins L.R., Wiertelak E.P., Goehler L.E., Mooney-Heiberger K., Martinez J., Furness L., Smith K.P., Maier S.F. Neurocircuitry of illness-induced hyperalgesia. Brain Res. 639:1994;283-299.
38. Wiertelak E.P., Roemer B., Maier S.F., Watkins L.R. Comparison of the effects of nucleus tractus solitarius and ventral medial medulla lesions on illness-induced and subcutaneous formalin-induced hyperalgesias. Brain Res. 748:1997;143-150.
39. Wiertelak E.P., Smith K.P., Furness L., Mooney-Heiberger K., Mayer T., Maier S.F., Watkins L.R. Acute and conditioned hyperalgesic responses to illness. Pain. 56:1994;227-234.
40. Wispelwey B., Lesse A.J., Hansen E.J., Scheld W.M. Haemophilas influenzae lipopolysaccharide-induced blood brain barrier permeability during experimental meningitis in the rat. J. Clin. Invest. 82:1988;1339-1346.
41. Wong M.-L., Bongiorno P.B., Rettori V., McCann S.M., Licinio J. Interleukin (IL) 1β, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: pathophysiological implications. Proc. Natl. Acad. Sci. U.S.A. 94:1997;227-232.
42. P.L. Wood, Roles of CNS macrophages in neurodegeneration, in: P.L. Wood (Ed.), Neuroinflammation Mechanisms and Management, Humana Press, Clifton, NJ, 1998, pp. 1-60.
43. Zhang X., Morrison D.C. Lipopolysaccharide-induced selective priming effects on TNF-α and nitric oxide production. J. Exp. Med. 177:1993;511-516.